Skip to main content
    D

    Dermata Therapeutics Inc (DRMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.91
    +0.25 (+37.19%)

    Market Cap: $4.41M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(16/21)
    Avg Surprise
    +0.45%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.55
    Range$-0.55 - $-0.55
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.61+9.8%
    60d ago$-0.63+12.7%
    30d ago$-0.63+12.7%
    7d ago$-0.63+12.7%
    Current$-0.55
    Revenue Consensus
    $25000
    Range$25000 - $25000
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.54
    Range$-0.54 - $-0.54
    1 analysts
    Revenue Consensus
    $75000
    Range$75000 - $75000
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.54---
    Sep 26EST
    		-$-0.55---
    Jun 26
    Reported Aug 11
    		$-0.74$-0.55-34.55%Miss+55.4%
    Mar 26
    Reported May 13
    		$-0.48$-0.53+9.43%Beat+61.6%
    Dec 25
    Reported Mar 26
    		$-1.52$-1.54+1.30%Beat+88.7%
    Sep 25
    Reported Nov 14
    		$-1.65$-1.59-3.77%Miss+91.9%
    Jun 25
    Reported Aug 13
    		$-1.66$-2.90+42.76%Beat+96.0%
    Mar 25
    Reported May 14
    		$-1.25$-0.45-178.11%Miss+73.4%
    Dec 24
    Reported Mar 17
    		$-13.40$-15.00+10.67%Beat-6281.0%
    Sep 24
    Reported Nov 13
    		$-20.40$-26.40+22.73%Beat+74.8%
    Jun 24
    Reported Aug 7
    		$-41.80$-37.90-10.29%Miss+55.8%
    Mar 24
    Reported May 15
    		$-4.70N/A+91.30%Beat+98.6%
    Dec 23
    Reported Mar 21
    		$-0.21N/A+73.08%Beat+99.9%
    Sep 23
    Reported Nov 9
    		$-81.00$-94.50+14.29%Beat+83.1%
    Jun 23
    Reported Aug 10
    		$-94.50$-138.00+31.52%Beat+83.6%
    Mar 23
    Reported May 11
    		$-340.50$-397.50+14.34%Beat+57.0%
    Dec 22
    Reported Feb 21
    		$-288.00$-480.00+40.00%Beat-6823.1%
    Sep 22
    Reported Nov 10
    		$-480.00$-528.00+9.09%Beat+76.7%
    Jun 22
    Reported Aug 15
    		$-576.00$-768.00+25.00%Beat-5042.9%
    Mar 22
    Reported May 16
    		$-792.00$-960.00+17.50%Beat-65566.2%
    Dec 21
    Reported Mar 28
    		$-4.16$-5.68+26.76%Beat-459.4%
    Sep 21
    Reported Nov 15
    		$-2064.00$-600.00-244.00%Miss-
    Jun 21
    Reported Aug 16
    		$-11.20N/A+50.35%Beat-
    Dec 20
    Reported Mar 31
    		$-1.21$0.00N/AMiss-
    Dec 19
    Reported Mar 30
    		$-0.74$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.21EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-183.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.81xQuick Ratio2.73x
    Trading Statistics
    Beta0.66Avg Volume7.69M
    52-Week High$4.3552-Week Low$0.84

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.99
    SMA 20$1.06
    SMA 50$1.21
    SMA 200$1.39
    EMA 10$0.95
    EMA 20$1.03
    EMA 50$1.15
    EMA 200$1.81

    MACD

    Line: -0.10Signal: -0.07Hist: -0.03

    ADX

    ADX: 16.4+DI: 25.8-DI: 32.3

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down96.0
    PSAR$0.60

    Bollinger Bands

    Upper Band$1.32
    Lower Band$0.80
    %B Position4925%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    39.9

    Momentum Oscillators

    Stoch %K22.7
    Stoch %D10.4
    Williams %R-46.8
    ROC (10d)-18.0%
    Momentum-0.20
    CCI (20d)-92.3
    MFI (14d)99.7

    Volatility Measures

    ATR (14d)$0.12(13.4%)
    StdDev (20d)0.13
    Hist Vol169.4%(High)

    Volume Flow

    VWAP$0.95
    OBV310.2M
    AD Line2.2B
    CMF (20d)-0.311

    Volume Metrics

    Avg Vol (20d)8.5M
    Vol Ratio19.9x(High)
    VWMA (20d)$0.91

    Pivot Points

    R3$1.07
    R2$0.97
    R1$0.81
    Pivot Point$0.71
    S1$0.56
    S2$0.45
    S3$0.30

    Advanced Oscillators

    TSI-34.71
    Ultimate Osc32.9
    KST-209.66

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$3.01M$1.93M$1.90M$1.76M$1.77M$2.34M$3.20M$3.23M$2.88M$3.20M$2.22M$1.81M
    R&D$212,563$383,724$526,620$504,387$617,835$1.28M$2.19M$2.40M$2.01M$1.60M$1.14M$902,977
    SG&A$2.80M$1.54M$1.37M$1.26M$1.15M$1.06M$1.01M$824,294$874,640$1.60M$1.08M$909,001
    Operating Income$-3,013,567$-1,926,382$-1,900,393$-1,760,671$-1,772,731$-2,339,803$-3,200,287$-3,225,653$-2,883,742$-3,203,560$-2,219,832$-1,811,978
    Interest Income$46,504$78,676$38,505$68,682$71,638$36,216$49,350$52,497$54,636$69,298$85,859$92,767
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-2,967,063$-1,847,706$-1,861,888$-1,691,989$-1,701,093$-2,303,587$-3,150,937$-3,173,156$-2,829,106$-3,134,262$-2,133,973$-1,719,211
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,967,063$-1,847,706$-1,861,888$-1,691,989$-1,701,093$-2,303,587$-3,150,937$-3,173,156$-2,829,106$-3,134,262$-2,133,973$-1,719,211
    EBITDA$-3,013,567$-1,926,382$-1,900,393$-1,760,671$-1,772,731$-2,339,803$-3,200,287$-3,225,653$-2,883,742$-3,203,560$-2,219,832$-1,811,978
    EBIT$-3,013,567$-1,926,382$-1,900,393$-1,760,671$-1,772,731$-2,339,803$-3,200,287$-3,225,653$-2,883,742$-3,203,560$-2,219,832$-1,811,978
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DRMA

    News

    Why Is Dermata Therapeutics Stock Gaining Thursday?

    Dermata Therapeutics (NASDAQ:DRMA) saw its stock jump nearly 34% on Thursday after announcing positive topline results from a cosmetic clinical study of its new Tome Foundational Treatment. The study showed improvements...

    Benzinga•10/15/26•Bullish

    Dermatology Developer Surges 39% as Clinical Study Validates Skincare Product

    Dermata Therapeutics Inc. (NASDAQ: DRMA) saw its shares surge 39% following the release of positive clinical data for its new skincare product...

    The Globe and Mail•10/15/26•Bullish

    Why Is Dermata Therapeutics Stock Gaining Thursday?

    Dermata Therapeutics Inc. (DRMA) saw its stock jump nearly 34% on Thursday after announcing positive topline results from a cosmetic clinical study of its new skin renewal treatment...

    TradingView•10/15/26•Bullish

    Top stock movements in today's session.

    This article provides an overview of the top stock gainers and losers in the US markets during Thursday's trading session. It highlights significant percentage changes for various companies...

    ChartMill•10/15/26•Bullish

    Top stock movements in today's session.

    This article provides an overview of the top stock gainers and losers during Thursday's trading session. It highlights several companies with significant price movements, including explanations for some changes...

    ChartMill•10/15/26•Bullish

    DRMA Valuation and Fair Value

    P/E
    -0.2x
    P/B
    1.0x
    See GNG's fair value

    DRMA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -183.9%

    DRMA Competitors

    CompanyTicker
    NuCana PLCNCNA
    Liminatus Pharma, Inc. Class A Common StockLIMN
    Enlivex Therapeutics LtdENLV
    Azitra IncAZTR
    Vivos Therapeutics IncVVOS
    Jupiter Neurosciences, Inc. Common StockJUNS
    bioAffinity Technologies, Inc.BIAF
    cbdMD IncYCBD

    Sector: Healthcare

    DRMA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -16.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.55
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About DRMA

    Does DRMA pay dividends?

    Dermata Therapeutics Inc (DRMA) does not currently pay a regular dividend.

    What is DRMA's market cap?

    Dermata Therapeutics Inc (DRMA) has a market capitalization of $4.41M with a current stock price of $0.91.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In